Clinical Trials
6 trialsNCT00003455 2013-07-10
Antineoplaston Therapy in Treating Women With Advanced Breast Cancer
National Cancer Institute (NCI)
Phase 2 Withdrawn
NCT00003486 2013-07-10
Antineoplaston Therapy in Treating Patients With Colon Cancer
National Cancer Institute (NCI)
Phase 2 Withdrawn
NCT00003502 2013-07-10
Antineoplaston Therapy in Treating Patients With Mantle Cell Lymphoma
National Cancer Institute (NCI)
Phase 2 Withdrawn
NCT00003514 2013-07-10
Antineoplaston Therapy in Treating Patients With Neuroendocrine Tumor That Is Metastatic or Unlikely to Respond to Surgery or Radiation Therapy
National Cancer Institute (NCI)
Phase 2 Withdrawn
NCT00003517 2013-07-10
Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer
National Cancer Institute (NCI)
Phase 2 Withdrawn
NCT00003536 2013-07-10
Methotrexate With or Without Antineoplaston Therapy in Treating Postmenopausal Women With Advanced Refractory Breast Cancer
National Cancer Institute (NCI)
Phase 2 Withdrawn